Time away from home
Just like last year, the majority (61%) of citizens across 27 countries agree that they have, or will spend at least one week away from home on vacation. However, there are some significant differences on a country by country level. Compared to last year, Turkey (74%, +9 pts.), China (62%, +8 pts.) and Sweden (72%, + 6pts.) have shown the largest increase among respondents who agree that they have, or will spend at least a week away from home. The number of respondents who agree with this statement has decreased most significantly in South Africa (57%, -12 pts.), Canada (56%, -7 pts.), France (59%, -7 pts.) and Spain (60%, -5 pts.).
Use them or lose them
Nearly two thirds (65%) of respondents agree that they will use up all vacation days that they are given. While the global number holds steady compared to last year, the most significant increase in a number of respondents who agree with this statement is found in Australia (53%, + 7pts.), France (66%, + 5 pts.), India (72%, + 5 pts.) and Saudi Arabia (81%, + 5 pts.). Most notable declines compared to last year are in Spain (71%, - 9 pts.), Belgium (78%, - 7 pts.), Hungary (69%, - 7 pts.) and South Korea (54%, - 6 pt.).
Put that phone away
Nearly half (47%) of respondents agree they never check work messages/emails while on vacation. The global average inched up one point since 2017. However, while the majority of countries see the number of people who chose to unplug on vacation increase compared to last year, most notably in China (44%, + 7 pts.), Sweden (58%, + 7 pts.), Peru (49%, + 6 pts.), India (54%, + 5 pts.), Saudi Arabia (53%, + 5 pts.) and Turkey (44%, + 5 pts.), the number of respondents who do not check their messages on vacation has declined in Poland (50%, - 7 pts.), Hungary (47%, - 6 pts.), Belgium (47%, - 7 pts.), South Africa (35%, - 5 pts.) and the United States (48%, - 4 pts.).
The survey instrument is conducted monthly in 27 countries around the world via the Ipsos Online Panel system. The countries reporting herein are Argentina, Australia, Belgium, Brazil, Canada, Chile, China, France, Great Britain, Germany, Hungary, India, Italy, Japan, Malaysia, Mexico, Peru, Poland, Russia, Saudi Arabia, Serbia, South Africa, South Korea, Spain, Sweden, Turkey and the United States of America. For the results of the survey presented herein, an international sample of 19,243 adults aged 18-64 in the US and Canada, and age 16-64 in all other countries, were interviewed between June 22nd and July 6th. Approximately 1000+ individuals participated on a country by country basis via the Ipsos Online Panel with the exception of Argentina, Belgium, Hungary, India, Mexico, Peru, Poland, Russia, Saudi Arabia, Serbia, South Africa, South Korea, Sweden and Turkey, where each have a sample approximately 500+. The precision of Ipsos online polls are calculated using a credibility interval with a poll of 1,000 accurate to +/- 3.5 percentage points and of 500 accurate to +/- 5.0 percentage points.
2018 Summer Holiday Plans Among Europeans, Americans and Asians
Europ Assistance releases its 18th annual Barometer on Summer holidays, focusing on Europe's, America's, and the first time Asia's holidays plans. In 2018, summer holiday plans are consolidating in all countries with a stable budget in Europe and the United States while increasing in Brazil. Millennials are disrupting traditional practices giving new strength to alternative lodging and online reviews. Social media are becoming a holidays must-have for Asia, the United States and Brazil while Europeans disconnect more easily.
[WEBINAR] Messaging & Motivation: Engaging Participants in Healthcare Research
August 27 - One of the biggest challenges researchers face is recruiting and retaining participants, especially for longitudinal studies or intense clinical trials. Join us for a complimentary webinar to learn innovative ways to enhance recruitment, and maintain participant engagement.
[EVENT] International Conference on Pharmacoepidemiology & Therapeutic Risk Management
August 22-26, Ipsos Healthcare’s Global Evidence, Value and Access (GEVA) team will be exhibiting at the 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) being held in Prague, CZ.